19.10
10-1月-25 15:00:05
15 分の遅延
株式
-2.15
-10.12%
本日の幅
18.67 - 20.80
ISIN
N/A
ソース
NASDAQ
Denali Therapeutics to Present New Data on ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at WORLDSymposium™
05 2 2021 08:00:00 提供 Nasdaq GlobeNewswire
Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors
11 1 2021 07:30:00 提供 Nasdaq GlobeNewswire
Denali Therapeutics Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Broad Therapeutic Portfolio in Neurodegeneration
08 1 2021 07:30:00 提供 Nasdaq GlobeNewswire